Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group

Saved in:
Bibliographic Details
Published inJournal of geriatric oncology Vol. 11; no. 1; pp. 121 - 124
Main Authors Papageorgiou, Sotirios G., Kontos, Christos K., Kotsianidis, Ioannis, Karousi, Paraskevi, Symeonidis, Argyris, Galanopoulos, Athanasios, Bouchla, Anthi, Hatzimichael, Eleftheria, Repousis, Panagiotis, Zikos, Panagiotis, Viniou, Nora-Athina, Poulakidas, Elias, Vassilakopoulos, Theodoros P., Diamantopoulos, Panagiotis, Mparmparousi, Despoina, Bouronikou, Eleni, Papadaki, Helen, Panayiotidis, Panayiotis, Pappa, Vasiliki
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.01.2020
Subjects
5-azacytidine
High-risk MDS
Older patients
Oligoblastic AML
Outcome
Prognosis
Older patients
5-azacytidine
Prognosis
High-risk MDS
Oligoblastic AML
Outcome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1879-4068
1879-4076
DOI:10.1016/j.jgo.2019.07.018